MiNK Therapeutics (INKT) Shares Outstanding (2020 - 2026)

MiNK Therapeutics has reported Shares Outstanding (Entity) for 7 years, with the latest figure at $5.0 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 25.3% year-over-year to $5.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.0 million (up 25.3% YoY) and the FY2025 annual result came in at $4.7 million, up 18.75% from the prior year.
• Shares Outstanding (Entity) rose to $5.0 million in Q1 2026 per INKT's latest filing, from $4.7 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $5.0 million in Q1 2026 and troughed at $3.4 million in Q1 2022.
• A 5-year average of $3.8 million and a median of $3.5 million in 2024 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Entity) jumped 39.5% in 2022, then climbed 1.16% in 2025.
• Over 5 years, Shares Outstanding (Entity) stood at $3.4 million in 2022, then advanced by 2.19% to $3.5 million in 2023, then gained by 14.54% to $4.0 million in 2024, then increased by 18.75% to $4.7 million in 2025, then advanced by 5.58% to $5.0 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $5.0 million, $4.7 million, and $4.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.